Drug Makers Find Little Federal Response To CO2 Shortage

By Jessica Karins / August 28, 2023 at 4:41 PM
Drug stakeholders are raising concerns that it is unclear who in the federal government is responsible for responding to a shortage of carbon dioxide (CO2), a component of the dry ice frequently used for transporting drugs, as scarcity of the gas impacts drug and vaccine access. The White House Office of Science and Technology Policy (OSTP) did not respond to inquiries from Inside Health Policy about whether it is taking action or engaging with stakeholders on the CO2 shortage,...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.